Comparable Efficacies of the Antimicrobial Peptide Human Lactoferrin 1-11 and Gentamicin in a Chronic Methicillin-Resistant Staphylococcus aureus Osteomyelitis Model
Open Access
- 1 June 2005
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 49 (6), 2438-2444
- https://doi.org/10.1128/aac.49.6.2438-2444.2005
Abstract
The therapeutic efficacy of an antimicrobial peptide, human lactoferrin 1-11 (hLF1-11), was investigated in a model of chronic methicillin-resistant Staphylococcus aureus (MRSA) (gentamicin susceptible) osteomyelitis in rabbits. We incorporated 50 mg hLF1-11/g or 50 mg gentamicin/g cement powder into a calcium phosphate bone cement (Ca-P) and injected it into the debrided tibial cavity, creating a local drug delivery system. The efficacy of hLF1-11 and gentamicin was compared to that of a sham-treated control (plain bone cement) (n = 6) and no treatment (infected only) (n = 5). The results were evaluated by microbiology, radiology, and histology. MRSA was recovered from all tibias in both control groups (n = 11). On the other hand, hLF1-11 and gentamicin significantly reduced the bacterial load. Furthermore, no growth of bacteria was detected in five out of eight and six out of eight specimens of the hLF1-11- and gentamicin-treated groups, respectively. These results were confirmed by a significant reduction of the histological disease severity score by hLF1-11 and gentamicin compared to both control groups. The hLF1-11-treated group also had a significantly lower radiological score compared to the gentamicin-treated group. This study demonstrates the efficacy of hLF1-11 incorporated into Ca-P bone cement as a possible therapeutic strategy for the treatment of osteomyelitis, showing efficacy comparable to that of gentamicin. Therefore, the results of this study warrant further preclinical investigations into the possibilities of using hLF1-11 for the treatment of osteomyelitis.Keywords
This publication has 33 references indexed in Scilit:
- Osteomyelitis prevention in rabbits using antimicrobial peptide hLF1-11- or gentamicin-containing calcium phosphate cementJournal of Antimicrobial Chemotherapy, 2004
- Vancomycin‐ResistantStaphylococcus aureusin the Absence of Vancomycin ExposureClinical Infectious Diseases, 2004
- Continuous-release or burst-release of the antimicrobial peptide human lactoferrin 1-11 (hLF1-11) from calcium phosphate bone substitutesJournal of Antimicrobial Chemotherapy, 2003
- Potential Therapeutic Role of Cationic Peptides in Three Experimental Models of Septic ShockAntimicrobial Agents and Chemotherapy, 2002
- Trabecular bone response to injectable calcium phosphate (Ca‐P) cementJournal of Biomedical Materials Research, 2002
- Antimicrobial peptides of multicellular organismsNature, 2002
- Human Lactoferrin and Peptides Derived from Its N Terminus Are Highly Effective against Infections with Antibiotic-Resistant BacteriaInfection and Immunity, 2001
- Osteomyelitis treated with gentamicin-PMMA beads: 100 patients followed for 1–12 yearsActa Orthopaedica, 1998
- Characterization of a rabbit model of staphylococcal osteomyelitisJournal of Orthopaedic Research, 1997
- Lessons Learned from Animal Models of OsteomyelitisClinical Infectious Diseases, 1988